Skip to main content

Security report for amicusassist.com

Amicus Therapeutics, Inc. · Healthcare · United States

Medium risk. 3 critical or high findings in Security headers and SSL/TLS.

Security score

72/100

Risk levelMedium

0–100, higher is better. How it is calculated

AmicusAssist.com is a patient support website operated by Amicus Therapeutics, Inc., focusing on providing assistance to patients prescribed medications for Fabry disease and late-onset Pompe disease (LOPD). The site offers services such as insurance verification, prescription coordination, financial assistance identification, and personalized patient support. The target audience is US residents undergoing treatment with Amicus Therapeutics medications. The website is professionally designed with clear navigation, mobile optimization, and accessibility features, reflecting a medium-sized healthcare support operation. Technically, the site employs modern web technologies including Bootstrap, jQuery, Google Tag Manager, and OneTrust for cookie consent management. Hosting and DNS are managed via reputable providers, with domain registration through Squarespace Domains II LLC. The site demonstrates good performance and SEO practices, with a comprehensive cookie consent mechanism and privacy policy hosted on a related Amicus domain. From a security perspective, the website uses HTTPS and cookie consent mechanisms but lacks DNSSEC and explicit security headers. No critical vulnerabilities or exposed sensitive data were detected. However, the absence of a published security policy or incident response contact is noted. The domain registration is consistent and appropriate for the business age and claims, enhancing trustworthiness. Overall, AmicusAssist.com presents a secure, compliant, and professional online presence for patient support in the rare disease healthcare sector. Strategic recommendations include enabling DNSSEC, implementing security headers, publishing a security policy, and adding a vulnerability disclosure mechanism to further strengthen security posture and trust.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…
  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching amicusassist.com

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
25
Email security
70
DNS health
75
Network security
100
GDPR outside view
88
Average
72

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention amicusassist.com, from OffSeq Breach.

No leaked records found

Breach holds no records for amicusassist.com right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Amicus Therapeutics operates AmicusAssist.com as a specialized patient support platform targeting individuals prescribed treatments for rare diseases such as Fabry and LOPD. The business model centers on providing comprehensive support services including insurance, prescription logistics, and financial aid navigation, enhancing patient adherence and satisfaction. The company leverages partnerships with healthcare professionals and maintains a focused US market presence. The website content and structure reflect a mature, medium-sized healthcare support service with consistent branding and clear trust signals. The linkage to the parent domain amicusrx.com consolidates corporate identity and legal compliance. Growth potential lies in expanding support services and digital engagement with patients and healthcare providers.

Security posture

The website demonstrates a moderate to good security maturity level with HTTPS enforced and cookie consent implemented via OneTrust. No critical security headers were detected in the provided data, and DNSSEC is not enabled, representing areas for improvement. There is no visible security policy or incident response contact information, which limits transparency and readiness for security incidents. No vulnerabilities or exposed sensitive data were found in the HTML content. The domain registration is stable and consistent with the business profile, supporting legitimacy. Compliance with GDPR is indicated through privacy policy and cookie consent mechanisms. Overall, the security posture is adequate for the business type but can be enhanced by adopting additional security best practices and transparency measures.

Recommendations

  1. Enable DNSSEC on the domain to improve DNS security and prevent spoofing.
  2. Implement standard security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
  3. Publish a dedicated security policy page outlining security practices and incident response procedures.
  4. Add a security.txt file to facilitate vulnerability disclosure and improve security transparency.
  5. Regularly audit third-party scripts and tracking tools to minimize privacy risks and ensure compliance.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Amicus Therapeutics, Inc.
Description
AMICUS ASSIST® provides support for patients prescribed Amicus Therapeutics medications, specifically for Fabry disease and late-onset Pompe disease (LOPD). The service offers insurance verification, prescription coordination, financial assistance identification, and personalized patient support.
Key services
Insurance coverage verification, Prescription delivery coordination, Financial assistance identification, Patient education and ongoing support
Content quality
good
Branding
consistent

Technology

Stack
Bootstrap, jQuery, Google Tag Manager, OneTrust Cookie Consent, Accessibility Suite (acsbapp.com)
Frameworks
Bootstrap
Platforms
Squarespace Domains (Registrar), Google Cloud DNS
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced (implied by domain and scripts)
  • Cookie consent banner with preference center
  • No exposed sensitive data in HTML
  • No vulnerable libraries detected

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is focused on patient support for rare diseases related to Amicus Therapeutics medications.
  2. Content is US resident focused with clear disclaimers and legal notices.
  3. Cookie consent and privacy mechanisms are implemented using OneTrust.
  4. No forms collecting personal data are present on the homepage; enrollment is done via patient referral forms submitted by doctors.
  5. Contact information is prominently displayed with toll-free phone numbers and Spanish language support.
  6. No social media links detected on the homepage.
  7. No explicit security policy or incident response information found.
  8. Website uses modern frontend technologies and accessibility features.
Technical notes

Notes

The website uses a modern frontend technology stack including Bootstrap for responsive design, jQuery for DOM manipulation, and Google Tag Manager for analytics and marketing tag management. Cookie consent and privacy compliance are managed through OneTrust, a leading consent management platform. Hosting and DNS are managed via reputable providers, with domain registration through Squarespace Domains II LLC. The site is mobile optimized and includes accessibility features via acsbapp.com. Performance is moderate with no major issues detected. There is no explicit CMS detected, suggesting a custom or static site architecture. Technical risks include lack of DNSSEC and missing security headers, which should be addressed to enhance security and trust.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with amicusassist.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review amicusassist.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.